(TAK) Takeda Pharmaceutical - Performance 14.4% in 12m
Compare TAK with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
5.13%
#52 in Group
Rel. Strength
72.31%
#2212 in Universe
Total Return 12m
14.40%
#42 in Group
Total Return 5y
5.35%
#58 in Group
P/E 31.6
79th Percentile in Group
P/E Forward 35.0
77th Percentile in Group
PEG 1.55
75th Percentile in Group
FCF Yield 7.07%
75th Percentile in Group
12m Total Return: TAK (14.4%) vs XLV (-0.5%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: TAK vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TAK
Total Return (including Dividends) | TAK | XLV | S&P 500 |
---|---|---|---|
1 Month | -3.10% | -7.37% | -5.89% |
3 Months | 12.29% | -4.55% | -12.45% |
12 Months | 14.40% | -0.54% | 6.72% |
5 Years | 5.35% | 46.59% | 101.06% |
Trend Score (consistency of price movement) | TAK | XLV | S&P 500 |
1 Month | -78.3% | -82.6% | -74.5% |
3 Months | 70.8% | -37.8% | -88.2% |
12 Months | 58.8% | -1.6% | 66.1% |
5 Years | -28.8% | 90.1% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #49 | 4.62% | 2.97% |
3 Month | #19 | 17.6% | 28.3% |
12 Month | #41 | 15.0% | 7.19% |
5 Years | #60 | -28.1% | -47.6% |
FAQs
Does TAK Takeda Pharmaceutical outperforms the market?
Yes,
over the last 12 months TAK made 14.40%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months TAK made 12.29%, while XLV made -4.55%.
Over the last 3 months TAK made 12.29%, while XLV made -4.55%.
Performance Comparison TAK vs Indeces and Sectors
TAK vs. Indices TAK is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 7.39% | 2.79% | 12.0% | 7.68% |
US NASDAQ 100 | QQQ | 8.25% | 3.18% | 12.6% | 8.87% |
US Dow Jones Industrial 30 | DIA | 8.56% | 2.72% | 11.5% | 9.09% |
German DAX 40 | DAX | 2.03% | 6.30% | -5.03% | -3.81% |
Shanghai Shenzhen CSI 300 | CSI 300 | 6.68% | 4.40% | 9.75% | 8.51% |
Hongkong Hang Seng | HSI | 3.10% | 6.72% | 10.5% | -1.82% |
India NIFTY 50 | INDA | 3.02% | -7.87% | 9.58% | 11.3% |
Brasil Bovespa | EWZ | 3.83% | 1.98% | 9.08% | 23.9% |
TAK vs. Sectors TAK is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 7.14% | 2.56% | 3.22% | 0.86% |
Consumer Discretionary | XLY | 8.26% | 0.82% | 9.29% | 5.18% |
Consumer Staples | XLP | 4.09% | -6.30% | 1.81% | 0.46% |
Energy | XLE | 2.67% | 6.98% | 11.0% | 24.7% |
Financial | XLF | 6.02% | 1.41% | 3.91% | -4.55% |
Health Care | XLV | 6.99% | 4.27% | 13.4% | 14.9% |
Industrial | XLI | 6.27% | 1.60% | 12.0% | 9.04% |
Materials | XLB | 5.67% | 3.55% | 19.1% | 21.9% |
Real Estate | XLRE | 2.05% | -0.21% | 10.7% | -2.71% |
Technology | XLK | 8.75% | 5.83% | 18.8% | 15.6% |
Utilities | XLU | 4.08% | -2.68% | 6.29% | -9.97% |
Aerospace & Defense | XAR | 5.70% | -3.14% | 2.27% | -9.76% |
Biotech | XBI | 3.83% | 8.78% | 26.6% | 23.3% |
Homebuilder | XHB | 6.44% | 3.74% | 29.9% | 23.5% |
Retail | XRT | 5.69% | -0.99% | 16.7% | 18.8% |